| __timestamp | Agios Pharmaceuticals, Inc. | Celldex Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 100371000 | 101881000 |
| Thursday, January 1, 2015 | 141827000 | 4011000 |
| Friday, January 1, 2016 | 220163000 | 102026000 |
| Sunday, January 1, 2017 | 292681000 | 96171000 |
| Monday, January 1, 2018 | 1397000 | 66449000 |
| Tuesday, January 1, 2019 | 1317000 | 42672000 |
| Wednesday, January 1, 2020 | 2805000 | 42534000 |
| Friday, January 1, 2021 | 18777000 | 3068000 |
| Saturday, January 1, 2022 | 1704000 | 1400000 |
| Sunday, January 1, 2023 | 9504000 | 3008000 |
| Monday, January 1, 2024 | 4165000 |
Unveiling the hidden dimensions of data
In the ever-evolving landscape of biotechnology, understanding cost structures is crucial. Agios Pharmaceuticals and Celldex Therapeutics, two prominent players, have shown intriguing trends in their cost of revenue from 2014 to 2023. Agios Pharmaceuticals experienced a significant peak in 2017, with costs soaring to nearly 300% of their 2014 levels. However, by 2023, their costs had decreased by approximately 90% from this peak, reflecting strategic shifts or operational efficiencies. In contrast, Celldex Therapeutics maintained a more stable trajectory, with costs peaking in 2016 and gradually declining by about 70% by 2023. These trends highlight the dynamic nature of cost management in the biotech sector, where companies must balance innovation with financial prudence. As the industry continues to evolve, monitoring these cost trends will be essential for investors and stakeholders alike.
Cost of Revenue: Key Insights for Novo Nordisk A/S and Agios Pharmaceuticals, Inc.
Cost Insights: Breaking Down Viatris Inc. and Agios Pharmaceuticals, Inc.'s Expenses
Cost of Revenue Comparison: Insmed Incorporated vs Agios Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs Celldex Therapeutics, Inc.
Cost of Revenue Trends: Catalent, Inc. vs Agios Pharmaceuticals, Inc.
Cost Insights: Breaking Down Corcept Therapeutics Incorporated and Celldex Therapeutics, Inc.'s Expenses
Cost of Revenue Trends: Alkermes plc vs Celldex Therapeutics, Inc.
Analyzing Cost of Revenue: PTC Therapeutics, Inc. and Celldex Therapeutics, Inc.
Cost of Revenue Trends: Perrigo Company plc vs Celldex Therapeutics, Inc.
Cost Insights: Breaking Down Supernus Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc.'s Expenses
Cost of Revenue: Key Insights for Agios Pharmaceuticals, Inc. and Evotec SE
Cost of Revenue Trends: Taro Pharmaceutical Industries Ltd. vs Celldex Therapeutics, Inc.